Purchases and Sales Made in Q3 2023 in Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE) during Q3 2023. The information is specifically focused on institutions that hold shares of Monte Rosa Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-15K- 14.93% |
$71.7K - $108K
|
85.5K
$518K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-15K- 29.39% |
$71.8K - $108K
|
36.1K
$219K
|
|
|
Nov 14, 2023
Q3 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-26K- 0.67% |
$124K - $187K
|
3.87M
$23.5M
|
|
|
Nov 09, 2023
Q3 2023
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-50.2K- 7.51% |
$240K - $363K
|
619K
$3.75M
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-166K- 4.29% |
$792K - $1.2M
|
3.69M
$22.4M
|